Screener
Alnylam Pharmaceuticals ALNY Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Alnylam Pharmaceuticals’s reported figures.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
FAQ
- What is Alnylam Pharmaceuticals's net debt?
- Alnylam Pharmaceuticals (ALNY) reported net debt of -$1.45B in Q2 2026.
- How has Alnylam Pharmaceuticals's net debt changed year-over-year?
- Alnylam Pharmaceuticals's net debt decreased by 71.9% year-over-year, from -$845.32M to -$1.45B.
- What is the long-term trend for Alnylam Pharmaceuticals's net debt?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's net debt has grown at a 128.8% compound annual growth rate (CAGR), from $22.14M to -$1.39B.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Alnylam Pharmaceuticals's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude